Skip to content

Complications in Central American Diabetic Patients: Historic Cohort

Complications in Central American Diabetic Patients: Historic Cohort

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02486237
Enrollment
225
Registered
2015-07-01
Start date
2015-09-30
Completion date
2016-04-30
Last updated
2016-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

diabetes mellitus, complications, prevalence

Brief summary

Retrospective, observational study to determine the prevalence of complications in Central American diabetic patients.

Detailed description

This is retrospective observational study aimed to determine the prevalence of complications in Central American diabetic patients. Patients included are treated in the usual outpatient practice setting and we will try to determine the prevalence of diabetic complications in these patients.

Interventions

None, it is an observational study

Sponsors

Novo Nordisk A/S
CollaboratorINDUSTRY
Clínica Los Yoses
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* type 2 diabetes mellitus diagnosed between 2004 and 2009 * seen by the attending physician for the first time between January and December 2009. * male or female patients between 18 and 80 years

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
Number of patients with microvascular and cardiovascular complicationsup to 10 years

Secondary

MeasureTime frame
Number of participants with at least one episode of hypoglycemiaup to 10 years
Number of patients with microvascular and cardiovascular complications stratified by their glucose controlup to 10 years
Number of patients with microvascular and cardiovascular complications stratified by blood pressure controlup to 10 years
Number of patients with microvascular and cardiovascular complications stratified by cholesterol levelsup to 10 years
Number of patients with microvascular and cardiovascular complications stratified by diabetes pharmacologic treatmentup to 10 years

Countries

Costa Rica, El Salvador, Guatemala, Honduras

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026